Global Health Services & Vulcain Partnership to Deliver Causal AI
12 January 2025 | Press Release
London, UK – January 20, 2025 – Global Health Services Ltd (GHS) and Vulcain Corp. (OTCMKTS: VLAI), today announced a Memorandum of Understanding (MoU) to establish a collaborative framework for the development and delivery of innovative causal AI healthcare solutions. The partnership will leverage Vulcain’s advanced causal AI-based Knowledge Grid and GHS’s expertise in evidence-based clinical services, research, and consultancy. The partnership goal is to enhance patient outcomes, improve operational efficiencies, and promote healthcare system sustainability across global markets.
“We are thrilled to partner with Vulcain to bring cutting-edge causal AI solutions to the healthcare industry,” said Claire Richardson, CEO of GHS. “This collaboration will enable us to develop and deploy innovative tools, expert healthcare knowledge and technologies that address some of the most pressing challenges in healthcare delivery and technology adoption.”
This collaboration seeks to enhance patient outcomes, improve operational efficiencies, and promote healthcare system sustainability across global markets. The joint projects will focus on co-developing and commercializing healthcare technologies and fostering knowledge exchange using collaborative expertise to address pressing challenges in healthcare delivery and technology adoption.
“This partnership is a testament to our commitment to advance the healthcare industry through the utilization of human-centric AI,” said Greg Duffell, CEO of Vulcain. “We look forward to working with GHS to deliver impactful solutions that improve patient care and transform healthcare systems for the NHS in the UK and globally.”
The Parties are confident that their combined expertise and resources will enable them to achieve the objectives outlined in the MoU and contribute meaningfully to addressing the ongoing challenges of delivering causes, recommendations, benchmarks, and solutions from healthcare data analysis.
For further information, please contact: Alexander Giles, Chief Innovation & Partnerships Officer, GHS, +44(0)1242 262007
About Global Health Services Ltd
Global Health Services Ltd (GHS) is a UK-based Healthtech consultancy and clinical services provider dedicated to delivering evidence-based healthcare innovations internationally. GHS works across research, medtech, and dual-model clinical services to transform health systems and improve patient outcomes.
About Vulcain Corp.
Vulcain is at the intersection of human and artificial intelligence, leading the charge to AI 3.0 with high-value revenue optimization and creation solutions for business. Vulcain’s Causal AI platform is used to harmonize, test, and validate data for extracting and commercializing through a Knowledge Grid. The Vulcain platform combines hundreds of millions of AI-ready high-value feature sets incorporating human domain knowledge. It can provide a ready-to-use solution in a standardized format usable across any domain or sector, customized, scaled and adapted for customer use cases and human intervention. With a commitment to human AI, excellence, sustainability, and customer-centric solutions, the company believes it is poised for long-term growth and success in the global AI marketplace.
For more information about the company and its wholly owned subsidiary Vulcain, Inc., email shareholders@vulcain.ai or visit www.vulcain.ai